Geode Capital Management LLC increased its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 7.7% in the second quarter, Holdings Channel.com reports. The firm owned 3,639,898 shares of the company’s stock after acquiring an additional 261,319 shares during the period. Geode Capital Management LLC’s holdings in Doximity were worth $223,829,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. Hantz Financial Services Inc. grew its holdings in Doximity by 148.9% during the second quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock valued at $28,000 after purchasing an additional 271 shares during the period. VSM Wealth Advisory LLC acquired a new position in Doximity during the first quarter valued at approximately $29,000. National Bank of Canada FI acquired a new position in Doximity during the first quarter worth approximately $33,000. Brooklyn Investment Group boosted its holdings in shares of Doximity by 70.7% during the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock worth $43,000 after buying an additional 309 shares during the period. Finally, Smartleaf Asset Management LLC grew its stake in Doximity by 176.0% in the 1st quarter. Smartleaf Asset Management LLC now owns 781 shares of the company’s stock valued at $46,000 after buying an additional 498 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on DOCS shares. Raymond James Financial set a $75.00 price objective on shares of Doximity in a research note on Wednesday, September 10th. Bank of America upgraded shares of Doximity from a “neutral” rating to a “buy” rating and increased their price target for the stock from $75.00 to $82.00 in a research report on Monday, October 27th. Canaccord Genuity Group decreased their price objective on shares of Doximity from $67.00 to $58.00 and set a “hold” rating on the stock in a research note on Monday, November 10th. Piper Sandler upped their target price on Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Finally, Evercore ISI lowered their price target on Doximity from $81.00 to $70.00 and set an “outperform” rating for the company in a report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $68.78.
Insider Buying and Selling
In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at approximately $1,318,103.16. The trade was a 9.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Regina M. Benjamin sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, October 10th. The stock was sold at an average price of $70.84, for a total transaction of $354,200.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at approximately $1,405,394.76. This represents a 20.13% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,000 shares of company stock valued at $2,339,580 over the last quarter. Corporate insiders own 31.30% of the company’s stock.
Doximity Stock Down 5.1%
Doximity stock opened at $47.07 on Tuesday. The stock has a market cap of $8.86 billion, a price-to-earnings ratio of 47.07, a PEG ratio of 4.10 and a beta of 1.36. The business has a 50-day simple moving average of $67.13 and a 200 day simple moving average of $62.46. Doximity, Inc. has a 52 week low of $46.83 and a 52 week high of $85.21.
Doximity (NASDAQ:DOCS – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the business posted $0.30 EPS. The company’s quarterly revenue was up 23.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
- Five stocks we like better than Doximity
- Quiet Period Expirations Explained
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- What Is WallStreetBets and What Stocks Are They Targeting?
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- How to Use High Beta Stocks to Maximize Your Investing Profits
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
